FNS has determined WIC state agencies may need the flexibility of providing non-contract formula through the end of February. It is USDA’s expectation that these extensions of flexibilities for non-contract formulas will be the final extensions, barring a significant change in the status of formula supply and availability.
This letter extends the expiration date for certain flexibilities for WIC state agencies following the Abbott Recall and infant formula shortage.
This memorandum provides state agencies with guidance for issuing the monthly Cash-Value Voucher/Benefit (CVV/B) for fruit and vegetable purchases to participants in WIC for FY 2023.
This letter extends the expiration date for certain flexibilities for WIC state agencies following the Abbott Recall and infant formula shortage.
This letter is in response to correspondence from WIC state agencies requesting flexibility with regard to the maximum monthly allowance (MMA) requirements in WIC as a result of the impact of the ongoing COVID-19 pandemic and the 2022 Abbott recall of certain powder infant formula on the nationwide supply chain leading to both periodic location and product-based WIC infant formula shortages.
This letter is in response to correspondence from WIC state agencies requesting program flexibility with regard to the maximum monthly allowance requirements in WIC as a result of the impact of the ongoing Coronavirus Disease 2019 pandemic and the 2022 Abbott recall of certain powder infant formula on the nationwide supply chain leading to both periodic location- and product-based WIC infant formula shortages.
This letter provides WIC state agencies flexibility related to WIC federal requirements. USDA is collaborating across a number of government agencies to ensure that WIC participants are able to obtain safe formula.
This memorandum sets forth applicable parameters for implementation of the infant formula cost containment contracts and waiver authority legislative provisions, effective immediately. The provisions set forth in this policy memorandum will also be incorporated into the federal WIC regulations through future rulemaking.
This letter is in response to correspondence from WIC state agencies requesting program flexibility from WIC federal requirements as a result of the impact of the ongoing Coronavirus Disease 2019 pandemic and the 2022 Abbott recall of certain powder infant formula and exempt infant formula on the nationwide supply chain leading to both periodic location- and product-based WIC infant formula and exempt infant formula shortages.
This letter is in response to correspondence from WIC state agencies requesting program flexibility with regard to medical documentation requirements in WIC, as a result of the impact of the ongoing Coronavirus Disease 2019 pandemic and the 2022 Abbott recall of certain powder infant formula on the nationwide supply chain leading to both periodic location- and product-based WIC infant formula shortages.